nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—CHRM3—ureter—uterine cancer	0.0721	0.234	CbGeAlD
Cyproheptadine—CHRM3—muscle of abdomen—uterine cancer	0.0519	0.168	CbGeAlD
Cyproheptadine—Neuritis—Progesterone—uterine cancer	0.0147	0.0213	CcSEcCtD
Cyproheptadine—Cholestasis—Progesterone—uterine cancer	0.0145	0.0209	CcSEcCtD
Cyproheptadine—CHRM3—exocrine gland—uterine cancer	0.0142	0.0461	CbGeAlD
Cyproheptadine—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.0193	CcSEcCtD
Cyproheptadine—HTR2A—artery—uterine cancer	0.00967	0.0314	CbGeAlD
Cyproheptadine—Hepatic failure—Progesterone—uterine cancer	0.00889	0.0128	CcSEcCtD
Cyproheptadine—Nasal congestion—Progesterone—uterine cancer	0.00877	0.0127	CcSEcCtD
Cyproheptadine—HTR2B—myometrium—uterine cancer	0.00875	0.0284	CbGeAlD
Cyproheptadine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00857	0.0124	CcSEcCtD
Cyproheptadine—Increased appetite—Progesterone—uterine cancer	0.0085	0.0123	CcSEcCtD
Cyproheptadine—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00805	0.0116	CcSEcCtD
Cyproheptadine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00802	0.0116	CcSEcCtD
Cyproheptadine—Diplopia—Progesterone—uterine cancer	0.00799	0.0115	CcSEcCtD
Cyproheptadine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0077	0.0111	CcSEcCtD
Cyproheptadine—Irritability—Progesterone—uterine cancer	0.00762	0.011	CcSEcCtD
Cyproheptadine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00691	0.00998	CcSEcCtD
Cyproheptadine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00688	0.00994	CcSEcCtD
Cyproheptadine—HTR2B—uterine cervix—uterine cancer	0.00681	0.0221	CbGeAlD
Cyproheptadine—Sweating increased—Progesterone—uterine cancer	0.00672	0.00972	CcSEcCtD
Cyproheptadine—HTR2B—smooth muscle tissue—uterine cancer	0.00662	0.0215	CbGeAlD
Cyproheptadine—HTR2B—decidua—uterine cancer	0.00649	0.0211	CbGeAlD
Cyproheptadine—Pollakiuria—Progesterone—uterine cancer	0.00638	0.00922	CcSEcCtD
Cyproheptadine—Chest discomfort—Etoposide—uterine cancer	0.00636	0.00919	CcSEcCtD
Cyproheptadine—Weight increased—Progesterone—uterine cancer	0.00628	0.00908	CcSEcCtD
Cyproheptadine—Hepatic failure—Dactinomycin—uterine cancer	0.00628	0.00908	CcSEcCtD
Cyproheptadine—HTR2B—endometrium—uterine cancer	0.00616	0.02	CbGeAlD
Cyproheptadine—Drowsiness—Progesterone—uterine cancer	0.00615	0.00889	CcSEcCtD
Cyproheptadine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00609	0.00881	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Progesterone—uterine cancer	0.00603	0.00872	CcSEcCtD
Cyproheptadine—Jaundice—Progesterone—uterine cancer	0.006	0.00867	CcSEcCtD
Cyproheptadine—CHRM3—smooth muscle tissue—uterine cancer	0.00595	0.0193	CbGeAlD
Cyproheptadine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00578	0.00835	CcSEcCtD
Cyproheptadine—SLC6A2—decidua—uterine cancer	0.00576	0.0187	CbGeAlD
Cyproheptadine—CHRM3—renal system—uterine cancer	0.00573	0.0186	CbGeAlD
Cyproheptadine—HTR1A—renal system—uterine cancer	0.00571	0.0185	CbGeAlD
Cyproheptadine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00569	0.00823	CcSEcCtD
Cyproheptadine—HTR2B—uterus—uterine cancer	0.00568	0.0184	CbGeAlD
Cyproheptadine—HRH1—myometrium—uterine cancer	0.0056	0.0182	CbGeAlD
Cyproheptadine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00558	0.00806	CcSEcCtD
Cyproheptadine—Hepatitis—Progesterone—uterine cancer	0.00552	0.00798	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00547	0.0079	CcSEcCtD
Cyproheptadine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00544	0.00786	CcSEcCtD
Cyproheptadine—HTR2C—female reproductive system—uterine cancer	0.00543	0.0176	CbGeAlD
Cyproheptadine—Tinnitus—Progesterone—uterine cancer	0.00515	0.00744	CcSEcCtD
Cyproheptadine—CHRM1—female reproductive system—uterine cancer	0.00513	0.0166	CbGeAlD
Cyproheptadine—HTR2B—female reproductive system—uterine cancer	0.0051	0.0166	CbGeAlD
Cyproheptadine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00501	0.00724	CcSEcCtD
Cyproheptadine—Tension—Progesterone—uterine cancer	0.00472	0.00682	CcSEcCtD
Cyproheptadine—Nervousness—Progesterone—uterine cancer	0.00467	0.00675	CcSEcCtD
Cyproheptadine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00467	0.00675	CcSEcCtD
Cyproheptadine—HTR2B—vagina—uterine cancer	0.00461	0.015	CbGeAlD
Cyproheptadine—CHRM3—female reproductive system—uterine cancer	0.00459	0.0149	CbGeAlD
Cyproheptadine—SLC6A2—female reproductive system—uterine cancer	0.00453	0.0147	CbGeAlD
Cyproheptadine—Vision blurred—Progesterone—uterine cancer	0.00453	0.00655	CcSEcCtD
Cyproheptadine—Tremor—Progesterone—uterine cancer	0.00451	0.00651	CcSEcCtD
Cyproheptadine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00449	0.00649	CcSEcCtD
Cyproheptadine—HRH1—epithelium—uterine cancer	0.00439	0.0143	CbGeAlD
Cyproheptadine—HRH1—uterine cervix—uterine cancer	0.00435	0.0141	CbGeAlD
Cyproheptadine—Vertigo—Progesterone—uterine cancer	0.00432	0.00624	CcSEcCtD
Cyproheptadine—Syncope—Progesterone—uterine cancer	0.00431	0.00623	CcSEcCtD
Cyproheptadine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00618	CcSEcCtD
Cyproheptadine—Palpitations—Progesterone—uterine cancer	0.00425	0.00614	CcSEcCtD
Cyproheptadine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00423	0.00612	CcSEcCtD
Cyproheptadine—HRH1—smooth muscle tissue—uterine cancer	0.00423	0.0137	CbGeAlD
Cyproheptadine—Loss of consciousness—Progesterone—uterine cancer	0.00423	0.00611	CcSEcCtD
Cyproheptadine—Neuritis—Epirubicin—uterine cancer	0.00423	0.00611	CcSEcCtD
Cyproheptadine—CHRM3—female gonad—uterine cancer	0.00418	0.0136	CbGeAlD
Cyproheptadine—Convulsion—Progesterone—uterine cancer	0.00417	0.00602	CcSEcCtD
Cyproheptadine—HRH1—decidua—uterine cancer	0.00415	0.0135	CbGeAlD
Cyproheptadine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.0059	CcSEcCtD
Cyproheptadine—Agranulocytosis—Dactinomycin—uterine cancer	0.00406	0.00587	CcSEcCtD
Cyproheptadine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.004	0.00579	CcSEcCtD
Cyproheptadine—Confusional state—Progesterone—uterine cancer	0.00396	0.00572	CcSEcCtD
Cyproheptadine—HRH1—endometrium—uterine cancer	0.00394	0.0128	CbGeAlD
Cyproheptadine—Oedema—Progesterone—uterine cancer	0.00393	0.00567	CcSEcCtD
Cyproheptadine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00566	CcSEcCtD
Cyproheptadine—Neuritis—Doxorubicin—uterine cancer	0.00391	0.00565	CcSEcCtD
Cyproheptadine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.00565	CcSEcCtD
Cyproheptadine—Hepatitis—Dactinomycin—uterine cancer	0.0039	0.00564	CcSEcCtD
Cyproheptadine—Shock—Progesterone—uterine cancer	0.00386	0.00558	CcSEcCtD
Cyproheptadine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.00557	CcSEcCtD
Cyproheptadine—Tachycardia—Progesterone—uterine cancer	0.00383	0.00554	CcSEcCtD
Cyproheptadine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00383	0.00554	CcSEcCtD
Cyproheptadine—HRH1—mammalian vulva—uterine cancer	0.00381	0.0124	CbGeAlD
Cyproheptadine—Hyperhidrosis—Progesterone—uterine cancer	0.00379	0.00548	CcSEcCtD
Cyproheptadine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00378	0.00546	CcSEcCtD
Cyproheptadine—Anorexia—Progesterone—uterine cancer	0.00374	0.00541	CcSEcCtD
Cyproheptadine—Hypotension—Progesterone—uterine cancer	0.00367	0.0053	CcSEcCtD
Cyproheptadine—HTR2A—epithelium—uterine cancer	0.00367	0.0119	CbGeAlD
Cyproheptadine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00359	0.00518	CcSEcCtD
Cyproheptadine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00514	CcSEcCtD
Cyproheptadine—Insomnia—Progesterone—uterine cancer	0.00355	0.00513	CcSEcCtD
Cyproheptadine—HTR2A—smooth muscle tissue—uterine cancer	0.00353	0.0115	CbGeAlD
Cyproheptadine—Paraesthesia—Progesterone—uterine cancer	0.00352	0.00509	CcSEcCtD
Cyproheptadine—Chills—Dactinomycin—uterine cancer	0.0035	0.00506	CcSEcCtD
Cyproheptadine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.00506	CcSEcCtD
Cyproheptadine—Somnolence—Progesterone—uterine cancer	0.00349	0.00504	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00348	0.00503	CcSEcCtD
Cyproheptadine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00347	0.00502	CcSEcCtD
Cyproheptadine—Dyspepsia—Progesterone—uterine cancer	0.00346	0.00499	CcSEcCtD
Cyproheptadine—Sweating increased—Etoposide—uterine cancer	0.00344	0.00497	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.00497	CcSEcCtD
Cyproheptadine—Decreased appetite—Progesterone—uterine cancer	0.00341	0.00493	CcSEcCtD
Cyproheptadine—HTR2A—renal system—uterine cancer	0.0034	0.011	CbGeAlD
Cyproheptadine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.0049	CcSEcCtD
Cyproheptadine—Fatigue—Progesterone—uterine cancer	0.00338	0.00489	CcSEcCtD
Cyproheptadine—Constipation—Progesterone—uterine cancer	0.00336	0.00485	CcSEcCtD
Cyproheptadine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.0048	CcSEcCtD
Cyproheptadine—HRH1—female reproductive system—uterine cancer	0.00326	0.0106	CbGeAlD
Cyproheptadine—Feeling abnormal—Progesterone—uterine cancer	0.00323	0.00467	CcSEcCtD
Cyproheptadine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00322	0.00465	CcSEcCtD
Cyproheptadine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00462	CcSEcCtD
Cyproheptadine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00457	CcSEcCtD
Cyproheptadine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.00452	CcSEcCtD
Cyproheptadine—Urticaria—Progesterone—uterine cancer	0.00312	0.00451	CcSEcCtD
Cyproheptadine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.00447	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Etoposide—uterine cancer	0.00309	0.00446	CcSEcCtD
Cyproheptadine—Jaundice—Etoposide—uterine cancer	0.00307	0.00444	CcSEcCtD
Cyproheptadine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00307	0.00443	CcSEcCtD
Cyproheptadine—Leukopenia—Dactinomycin—uterine cancer	0.00304	0.0044	CcSEcCtD
Cyproheptadine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.0044	CcSEcCtD
Cyproheptadine—HTR2B—lymph node—uterine cancer	0.00298	0.00969	CbGeAlD
Cyproheptadine—HRH1—female gonad—uterine cancer	0.00297	0.00964	CbGeAlD
Cyproheptadine—HRH1—vagina—uterine cancer	0.00295	0.00958	CbGeAlD
Cyproheptadine—Agranulocytosis—Etoposide—uterine cancer	0.00294	0.00425	CcSEcCtD
Cyproheptadine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00424	CcSEcCtD
Cyproheptadine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00408	CcSEcCtD
Cyproheptadine—Asthenia—Progesterone—uterine cancer	0.00282	0.00407	CcSEcCtD
Cyproheptadine—Oedema—Dactinomycin—uterine cancer	0.00277	0.00401	CcSEcCtD
Cyproheptadine—HTR2A—female reproductive system—uterine cancer	0.00272	0.00884	CbGeAlD
Cyproheptadine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00272	0.00393	CcSEcCtD
Cyproheptadine—Diarrhoea—Progesterone—uterine cancer	0.00269	0.00388	CcSEcCtD
Cyproheptadine—SLC6A2—lymph node—uterine cancer	0.00265	0.00861	CbGeAlD
Cyproheptadine—Anorexia—Dactinomycin—uterine cancer	0.00264	0.00382	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—uterine cancer	0.00261	0.00377	CcSEcCtD
Cyproheptadine—Dizziness—Progesterone—uterine cancer	0.0026	0.00375	CcSEcCtD
Cyproheptadine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00369	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—uterine cancer	0.00255	0.00368	CcSEcCtD
Cyproheptadine—Chills—Etoposide—uterine cancer	0.00254	0.00366	CcSEcCtD
Cyproheptadine—Vomiting—Progesterone—uterine cancer	0.0025	0.00361	CcSEcCtD
Cyproheptadine—Rash—Progesterone—uterine cancer	0.00247	0.00358	CcSEcCtD
Cyproheptadine—Dermatitis—Progesterone—uterine cancer	0.00247	0.00357	CcSEcCtD
Cyproheptadine—HTR2A—vagina—uterine cancer	0.00246	0.008	CbGeAlD
Cyproheptadine—Headache—Progesterone—uterine cancer	0.00246	0.00355	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—uterine cancer	0.00244	0.00352	CcSEcCtD
Cyproheptadine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.00352	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—uterine cancer	0.00241	0.00349	CcSEcCtD
Cyproheptadine—Decreased appetite—Dactinomycin—uterine cancer	0.00241	0.00349	CcSEcCtD
Cyproheptadine—Fatigue—Dactinomycin—uterine cancer	0.00239	0.00346	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—uterine cancer	0.00236	0.00341	CcSEcCtD
Cyproheptadine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.0034	CcSEcCtD
Cyproheptadine—Nausea—Progesterone—uterine cancer	0.00233	0.00337	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—uterine cancer	0.00229	0.00331	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dactinomycin—uterine cancer	0.00229	0.0033	CcSEcCtD
Cyproheptadine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00327	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—uterine cancer	0.00226	0.00326	CcSEcCtD
Cyproheptadine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00324	CcSEcCtD
Cyproheptadine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00324	CcSEcCtD
Cyproheptadine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00322	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—uterine cancer	0.00221	0.00319	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—uterine cancer	0.0022	0.00318	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—uterine cancer	0.00216	0.00313	CcSEcCtD
Cyproheptadine—Convulsion—Etoposide—uterine cancer	0.00213	0.00308	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—uterine cancer	0.00212	0.00306	CcSEcCtD
Cyproheptadine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00305	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—uterine cancer	0.00202	0.00293	CcSEcCtD
Cyproheptadine—Asthenia—Dactinomycin—uterine cancer	0.00199	0.00288	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Etoposide—uterine cancer	0.00197	0.00284	CcSEcCtD
Cyproheptadine—Tachycardia—Etoposide—uterine cancer	0.00196	0.00283	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—uterine cancer	0.00194	0.00281	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—uterine cancer	0.00191	0.00277	CcSEcCtD
Cyproheptadine—HRH1—lymph node—uterine cancer	0.00191	0.00619	CbGeAlD
Cyproheptadine—Diarrhoea—Dactinomycin—uterine cancer	0.0019	0.00274	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—uterine cancer	0.00188	0.00271	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—uterine cancer	0.00183	0.00264	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00181	0.00261	CcSEcCtD
Cyproheptadine—Paraesthesia—Etoposide—uterine cancer	0.0018	0.00261	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—uterine cancer	0.0018	0.0026	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—uterine cancer	0.00179	0.00258	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—uterine cancer	0.00176	0.00255	CcSEcCtD
Cyproheptadine—Vomiting—Dactinomycin—uterine cancer	0.00176	0.00255	CcSEcCtD
Cyproheptadine—Rash—Dactinomycin—uterine cancer	0.00175	0.00253	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—uterine cancer	0.00175	0.00252	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—uterine cancer	0.00173	0.0025	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00173	0.0025	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—uterine cancer	0.00172	0.00249	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—uterine cancer	0.00172	0.00248	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—uterine cancer	0.00169	0.00245	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00167	0.00242	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—uterine cancer	0.00167	0.00241	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—uterine cancer	0.00165	0.00239	CcSEcCtD
Cyproheptadine—Nausea—Dactinomycin—uterine cancer	0.00165	0.00238	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—uterine cancer	0.00165	0.00238	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—uterine cancer	0.00163	0.00236	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.0016	0.00231	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—uterine cancer	0.0016	0.00231	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—uterine cancer	0.00159	0.0023	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—uterine cancer	0.00158	0.00229	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—uterine cancer	0.00152	0.0022	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—uterine cancer	0.00148	0.00213	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—uterine cancer	0.00147	0.00212	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—uterine cancer	0.00144	0.00208	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—uterine cancer	0.00142	0.00205	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—uterine cancer	0.00137	0.00199	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—uterine cancer	0.00137	0.00198	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—uterine cancer	0.00135	0.00196	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—uterine cancer	0.00134	0.00194	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—uterine cancer	0.00133	0.00192	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—uterine cancer	0.00132	0.0019	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—uterine cancer	0.0013	0.00188	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—uterine cancer	0.00128	0.00185	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—uterine cancer	0.00127	0.00183	CcSEcCtD
Cyproheptadine—Rash—Etoposide—uterine cancer	0.00127	0.00183	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—uterine cancer	0.00126	0.00183	CcSEcCtD
Cyproheptadine—Headache—Etoposide—uterine cancer	0.00126	0.00182	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—uterine cancer	0.00125	0.00181	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—uterine cancer	0.00124	0.00179	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—uterine cancer	0.00124	0.00179	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—uterine cancer	0.00124	0.00179	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—uterine cancer	0.00123	0.00178	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—uterine cancer	0.00122	0.00176	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—uterine cancer	0.00121	0.00175	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—uterine cancer	0.0012	0.00174	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—uterine cancer	0.00119	0.00173	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—uterine cancer	0.00119	0.00172	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—uterine cancer	0.00117	0.00169	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—uterine cancer	0.00115	0.00166	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—uterine cancer	0.00114	0.00165	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—uterine cancer	0.00114	0.00165	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—uterine cancer	0.00113	0.00164	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—uterine cancer	0.00113	0.00163	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—uterine cancer	0.00113	0.00163	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—uterine cancer	0.00112	0.00162	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—uterine cancer	0.00111	0.0016	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—uterine cancer	0.00111	0.0016	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—uterine cancer	0.0011	0.00159	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—uterine cancer	0.0011	0.00159	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—uterine cancer	0.00109	0.00157	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—uterine cancer	0.00107	0.00155	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—uterine cancer	0.00105	0.00152	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—uterine cancer	0.00105	0.00152	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—uterine cancer	0.00104	0.00151	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—uterine cancer	0.00102	0.00148	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—uterine cancer	0.00102	0.00147	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—uterine cancer	0.00102	0.00147	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—uterine cancer	0.00102	0.00147	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—uterine cancer	0.00101	0.00146	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—uterine cancer	0.00101	0.00146	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—uterine cancer	0.001	0.00145	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—uterine cancer	0.000993	0.00143	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—uterine cancer	0.000991	0.00143	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—uterine cancer	0.000978	0.00141	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—uterine cancer	0.000973	0.00141	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—uterine cancer	0.00097	0.0014	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—uterine cancer	0.000962	0.00139	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—uterine cancer	0.000942	0.00136	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—uterine cancer	0.000935	0.00135	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—uterine cancer	0.000928	0.00134	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—uterine cancer	0.000926	0.00134	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—uterine cancer	0.000917	0.00132	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—uterine cancer	0.000905	0.00131	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—uterine cancer	0.000898	0.0013	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—uterine cancer	0.000894	0.00129	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—uterine cancer	0.000891	0.00129	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—uterine cancer	0.000858	0.00124	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—uterine cancer	0.000827	0.0012	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—uterine cancer	0.000808	0.00117	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—uterine cancer	0.00077	0.00111	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—uterine cancer	0.000747	0.00108	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—uterine cancer	0.000744	0.00108	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—uterine cancer	0.000716	0.00103	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—uterine cancer	0.000713	0.00103	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—uterine cancer	0.00071	0.00103	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—uterine cancer	0.000709	0.00102	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—uterine cancer	0.000705	0.00102	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—uterine cancer	0.000689	0.000995	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—uterine cancer	0.000669	0.000966	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—uterine cancer	0.000662	0.000957	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—uterine cancer	0.000657	0.000949	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—uterine cancer	0.000656	0.000948	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—uterine cancer	0.000652	0.000943	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—uterine cancer	0.000619	0.000894	CcSEcCtD
